Evaluating the cost-effectiveness of statins.
Hay
Joel W
JW
D003362:Cost-Benefit Analysis; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000191:economics* / Q000627:therapeutic use; D014481:United States
D000960:Hypolipidemic Agents